ImmunityBio, Inc.
IBRX
주식 순위
#2232
ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and... ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases. Its innovative approach relies on a comprehensive suite of immunotherapy and cell therapy platforms. These advanced technologies include novel antibody-cytokine fusion proteins, synthetically engineered immunomodulators, cutting-edge vaccine technologies, natural killer (NK) cell therapies, and strategies that harness the adaptive (T-cell) immune system. ImmunityBio currently has several therapeutic candidates in advanced clinical development, with agents undergoing Phase II or III trials. These investigational treatments are aimed at various liquid and solid tumors, such as bladder, pancreatic, and lung cancers, as well as significant infectious pathogens including SARS-CoV-2 and HIV. The company actively engages in strategic partnerships, holding collaboration agreements with esteemed organizations like the National Cancer Institute, the National Institute of Deafness and Communication Disorders, and Amyris, Inc. Additionally, ImmunityBio has secured licensing agreements with numerous entities, including CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc.
주가
$8.55
마지막 동기화: 2026-10-19
시가총액
$9.06B
변동 (1일)
-6.84%
변동 (1년)
249.08%
국가
US
거래 ImmunityBio, Inc. (IBRX)
카테고리
Healthcare
ImmunityBio, Inc. (IBRX)의 주식 분할 이력
ImmunityBio, Inc. 주식 (심볼: IBRX)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Oct 20, 2026에 발생했습니다.
Oct 20, 2026 이전에 매수한 IBRX 주식 1주는 현재 0주의 IBRX 주식에 해당합니다.
가장 최근의 분할은 Oct 20, 2026에 발생했습니다.
Oct 20, 2026 이전에 매수한 IBRX 주식 1주는 현재 0주의 IBRX 주식에 해당합니다.
주식 분할 목록
| 연도 | 주식 분할 | 배수 | 누적 배수 |
|---|---|---|---|
| 제공된 날짜에 대한 데이터가 충분하지 않습니다. | |||
유사 기업 또는 경쟁사의 주식 분할
| 회사 | 주식 분할 횟수 | 누적 배수 | 국가 |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
